Abstract
The CCR5/CCL5 axis plays a key role in CRC. We previously showed that polymorphisms in CCR5/CCL5 are associated with outcome in patients (pts) with metastatic CRC. Here we aimed to characterize the molecular features associated with CCR5/CCL5 expression in CRC and whether CCR5/CCL5 levels could impact treatment outcome.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
